EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. (Q37589341)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 August 2009

Language	Label	Description	Also known as
English	EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.	scientific article published on 28 August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

A G Pallis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

C Gridelli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J P van Meerbeeck

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

L Greillier

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

U Wedding

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

D Lacombe

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J Welch

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Aapro

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

692-706

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19717538%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Geriatric oncology: challenges for the new century

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Analysis of treatment practices for elderly cancer patients in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

The changing epidemiology of lung cancer in Europe

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Understanding the attitudes of the elderly towards enrolment into cancer clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Cancer-directed surgery for localized disease: decreased use in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Pulmonary resection for malignancy in the elderly: is age still a risk factor?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Outcome of surgery for lung cancer in young and elderly patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Surgical treatment for lung cancer in octogenarians.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Lung cancer in octogenarians: factors affecting long-term survival following resection

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Advanced age does not exclude lobectomy for non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Surgery for non-small cell carcinoma in geriatric patients: 15-year experience

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Surgical resection for lung cancer in the octogenarian

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Surgery of non-small cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Comorbidity in older surgical cancer patients: influence on patient care and outcome.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

The use of surgery to treat lung cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

BTS guidelines: guidelines on the selection of patients with lung cancer for surgery

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

VATS major pulmonary resection revisited--controversies, techniques, and results

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Video-assisted thoracic surgery in the elderly. A review of 307 cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Postoperative radiotherapy in radically resected non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Management of lung cancer in older adults

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Involved-field radiotherapy alone for early-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

New approaches to radiotherapy as definitive treatment for inoperable lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Treatment of locally advanced non-small cell lung cancer in the elderly.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Lung tumor markers of cytokeratin origin: an overview

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Non-small cell lung cancer in octogenarians: treatment practices and preferences

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Long-term trends in cancer mortality in the United States, 1930-1998.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Influence of age and comorbidities on the chemotherapeutic management of lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Geriatric Pharmacology: Basic and Clinical Considerations*

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Drug-drug interactions in oncology: why are they important and can they be minimized?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

A reevaluation of the duration of survival after the onset of dementia.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Body mass index and mortality among older people living in the community.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Cancer in the older person

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Comprehensive geriatric assessment and its clinical impact in oncology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Effect of Age on Survival of Clinical Stage I Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP360

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37589341&oldid=2098821062"